FLT3 mutation Assay Laboratory Cross Validation: Results from the CALGB 10603/Ratify Trial in Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
• 作者

  Thiede Christian; Prior Thomas W.; Lavorgna Serena; Krauter Juergen; Barragan Eva; Nomdedeu Josep; Jansen Joop H.; Wei Andrew H.; Zhao Weiqiang; Li Xiaohong; Pallaud Celine; Tiecke Eva; Larson Richard A.; Bloomfield Clara D.; Doehner Hartmut; Ehninger Gerhard; Stone Richard M.; Doehner Konstanze;

  展开▼
• 作者单位

  Univ Klinikum Carl Gustav Carus Med Klin &

  Poliklin 1 Dresden Germany;

  Ohio State Univ Ctr Comprehens Canc Columbus OH 43210 USA;

  Univ Tor Vergata Dept Biomed &

  Prevent Rome Italy;

  Municipal Hosp Braunschweig Dept Internal Med 3 Braunschweig Germany;

  Hosp Univ La Fe Valencia Dept Hematol Valencia Spain;

  Univ Barcelona Hematol Dept Hosp Santa Creu &

  St Pau Barcelona Spain;

  Radboud Univ Nijmegen Med Ctr Lab Hematol Dept Lab Med Nijmegen Netherlands;

  Alfred Hosp Dept Clin Haematol Melbourne Vic Australia;

  Ohio State Univ Ctr Comprehens Canc Columbus OH 43210 USA;

  Novartis Pharmaceut Basel Switzerland;

  Novartis Pharmaceut Oncol Precis Med Novartis Oncol BU Basel Switzerland;

  Novartis Pharmaceut Basel Switzerland;

  Univ Chicago Ctr Comprehens Canc Chicago IL 60637 USA;

  Ohio State Univ Ctr Comprehens Canc Columbus OH 43210 USA;

  Univ Hosp Ulm Dept Internal Med 3 Ulm Germany;

  Univ Klinikum Carl Gustav Carus TU Dresden Med Klin &

  Poliklin 1 Dresden Germany;

  Dana Farber Partners Canc Care Boston MA USA;

  Univ Hosp Ulm Dept Internal Med 3 Ulm Germany;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词